StockData
ResMed Inc logo

ResMed Inc (RMD) stock

RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3012% below fair value
$235.63−1.25 (-0.53%)

Close on Nov 20, 2026Market cap $33.14BP/E 21.5Yield 1.02%

ResMed gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

ResMed's gross profit for the twelve months ending Sep 30, 2026 was $3.50B, up 11.0% year over year. For fiscal 2026 it was $3.45B, up 13.0% from the year before. Over ten years it grew 12.5% a year on average. The highest annual figure on record is $3.45B in fiscal 2026.

Annual gross profit

PeriodPeriod endValueChange
FY2026Jun 30, 2026$3.45B+13.0%
FY2025Jun 30, 2025$3.05B+15.1%
FY2024Jun 30, 2024$2.66B+12.7%
FY2023Jun 30, 2023$2.36B+16.4%
FY2022Jun 30, 2022$2.02B+10.1%
FY2021Jun 30, 2021$1.84B+7.1%
FY2020Jun 30, 2020$1.72B+15.0%
FY2019Jun 30, 2019$1.49B+11.9%
FY2018Jun 30, 2018$1.33B+11.1%
FY2017Jun 30, 2017$1.20B+12.7%
FY2016Jun 30, 2016$1.07B+5.4%
FY2015Jun 30, 2015$1.01B+2.2%
FY2014Jun 30, 2014$989.79M+5.2%
FY2013Jun 30, 2013$940.66M+14.6%
FY2012Jun 30, 2012$820.74M+10.7%
FY2011Jun 30, 2011$741.33M+13.1%
FY2010Jun 30, 2010$655.48M+18.4%
FY2009Jun 30, 2009$553.80M–

Quarterly gross profit

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026$870.57M+6.5%
Q4 FY2026CQ2 2026Jun 30, 2026$861.22M+5.0%
Q3 FY2026CQ1 2026Mar 31, 2026$890.98M+16.3%
Q2 FY2026CQ4 2025Dec 31, 2025$878.72M+17.0%
Q1 FY2026CQ3 2025Sep 30, 2025$817.66M+14.0%
Q4 FY2025CQ2 2025Jun 30, 2025$820.07M+14.6%
Q3 FY2025CQ1 2025Mar 31, 2025$766.41M+10.6%
Q2 FY2025CQ4 2024Dec 31, 2024$751.28M+16.1%
Q1 FY2025CQ3 2024Sep 30, 2024$717.22M+19.5%
Q4 FY2024CQ2 2024Jun 30, 2024$715.53M+15.9%
Q3 FY2024CQ1 2024Mar 31, 2024$692.78M+12.1%
Q2 FY2024CQ4 2023Dec 31, 2023$646.93M+11.6%
Q1 FY2024CQ3 2023Sep 30, 2023$600.06M+11.0%
Q4 FY2023CQ2 2023Jun 30, 2023$617.39M+18.2%
Q3 FY2023CQ1 2023Mar 31, 2023$617.75M+25.8%
Q2 FY2023CQ4 2022Dec 31, 2022$579.72M+15.0%
Q1 FY2023CQ3 2022Sep 30, 2022$540.81M+6.8%
Q4 FY2022CQ2 2022Jun 30, 2022$522.51M+6.5%
Q3 FY2022CQ1 2022Mar 31, 2022$491.20M+9.8%
Q2 FY2022CQ4 2021Dec 31, 2021$504.32M+9.0%
Q1 FY2022CQ3 2021Sep 30, 2021$506.29M+15.4%
Q4 FY2021CQ2 2021Jun 30, 2021$490.70M+9.2%
Q3 FY2021CQ1 2021Mar 31, 2021$447.26M-0.5%
Q2 FY2021CQ4 2020Dec 31, 2020$462.48M+8.3%
Q1 FY2021CQ3 2020Sep 30, 2020$438.66M+12.0%
Q4 FY2020CQ2 2020Jun 30, 2020$449.37M+11.7%
Q3 FY2020CQ1 2020Mar 31, 2020$449.66M+18.0%
Q2 FY2020CQ4 2019Dec 31, 2019$427.13M+14.0%
Q1 FY2020CQ3 2019Sep 30, 2019$391.62M+14.1%
Q4 FY2019CQ2 2019Jun 30, 2019$402.43M+20.1%
Q3 FY2019CQ1 2019Mar 31, 2019$380.97M+10.7%
Q2 FY2019CQ4 2018Dec 31, 2018$374.53M+7.1%
Q1 FY2019CQ3 2018Sep 30, 2018$343.09M+12.3%
Q4 FY2018CQ2 2018Jun 30, 2018$335.21M+3.5%
Q3 FY2018CQ1 2018Mar 31, 2018$344.30M+14.9%
Q2 FY2018CQ4 2017Dec 31, 2017$349.79M+13.2%
Q1 FY2018CQ3 2017Sep 30, 2017$305.61M–
Q4 FY2017CQ2 2017Jun 30, 2017$323.78M–
Q3 FY2017CQ1 2017Mar 31, 2017$299.71M–
Q2 FY2017CQ4 2016Dec 31, 2016$309.07M–

More ResMed figures

See a number that looks wrong?